Hiroshi Ito Selected Research

Hiroshi Ito Research Topics

Disease

44	Neoplasms (Cancer) 12/2021 - 01/2002
43	Heart Failure 03/2022 - 02/2005
31	Myocardial Infarction 05/2022 - 01/2003
25	Coronary Artery Disease (Coronary Atherosclerosis) 05/2022 - 01/2011
24	Infections 02/2022 - 04/2002
22	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 04/2003
22	Hypertension (High Blood Pressure) 11/2021 - 04/2007
21	Inflammation (Inflammations) 06/2022 - 01/2002
17	Pulmonary Arterial Hypertension 01/2021 - 05/2010
16	Atrial Fibrillation 01/2022 - 05/2003
14	Hypertrophy 05/2019 - 08/2002
14	Schizophrenia (Dementia Praecox) 11/2017 - 02/2008
13	Diabetes Mellitus 05/2022 - 01/2003
12	Stroke (Strokes) 03/2022 - 02/2004
12	Thrombosis (Thrombus) 01/2022 - 09/2004
12	Pulmonary Hypertension 01/2022 - 02/2009
11	Insulin Resistance 03/2022 - 09/2009
11	Atherosclerosis 01/2022 - 04/2006
11	Cardiomegaly (Heart Hypertrophy) 05/2019 - 08/2002
10	Fibrosis (Cirrhosis) 04/2021 - 08/2009
10	Chronic Renal Insufficiency 01/2019 - 01/2011
10	Ischemia 06/2017 - 08/2003
9	Type 2 Diabetes Mellitus (MODY) 02/2022 - 07/2014
9	Hemorrhage 01/2022 - 01/2005
9	Wounds and Injuries (Trauma) 12/2021 - 09/2002
8	Periodontitis 04/2022 - 12/2016
8	Acute Coronary Syndrome 01/2022 - 02/2004
8	Stable Angina 02/2021 - 02/2007
8	Body Weight (Weight, Body) 01/2021 - 02/2014
8	Hypoxia (Hypoxemia) 01/2018 - 08/2002
8	Familial Primary Pulmonary Hypertension 12/2016 - 01/2010
8	Infarction (Infarctions) 06/2012 - 01/2003
7	Pathologic Constriction (Stenosis) 12/2022 - 06/2008
7	Rheumatoid Arthritis 02/2022 - 02/2011
7	Alzheimer Disease (Alzheimer's Disease) 02/2021 - 11/2008
7	Left Ventricular Dysfunction 01/2021 - 01/2011
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2020 - 12/2011
7	Necrosis 12/2016 - 07/2004
6	Sarcoidosis (Schaumann Disease) 02/2022 - 09/2014
6	Hypotension (Low Blood Pressure) 11/2021 - 01/2011
6	Atrial Heart Septal Defects (Atrial Septal Defect) 05/2021 - 01/2012
6	Hypertriglyceridemia 05/2019 - 08/2011
6	Ventricular Fibrillation 05/2019 - 10/2010
6	Neoplasm Metastasis (Metastasis) 01/2018 - 05/2003
6	Mental Disorders (Mental Disorder) 01/2017 - 10/2005
6	Pancreatic Neoplasms (Pancreatic Cancer) 11/2014 - 10/2003
5	Myocardial Ischemia (Ischemic Heart Diseases) 03/2022 - 11/2003
5	Hyperglycemia 01/2021 - 01/2003

Drug/Important Bio-Agent (IBA)

22	Biomarkers (Surrogate Marker)IBA 06/2022 - 10/2007
20	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2022 - 09/2005
19	Pharmaceutical PreparationsIBA 01/2021 - 04/2002
12	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2002
12	Epoprostenol (Prostacyclin)FDA LinkGeneric 11/2019 - 10/2010
10	Glucose (Dextrose)FDA LinkGeneric 03/2022 - 01/2003
10	Oxygen (Dioxygen)IBA 01/2022 - 06/2002
10	LipidsIBA 01/2021 - 03/2006
9	CalciumIBA 06/2022 - 12/2012
9	Dopamine (Intropin)FDA LinkGeneric 06/2014 - 09/2006
8	CytokinesIBA 04/2022 - 03/2004
8	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 07/2009
8	Angiotensin Receptor AntagonistsIBA 03/2019 - 04/2006
8	C-Reactive ProteinIBA 01/2018 - 09/2005
7	SteroidsIBA 01/2022 - 05/2006
7	LDL CholesterolIBA 12/2020 - 02/2013
7	Eicosapentaenoic AcidIBA 06/2018 - 10/2014
7	Antipsychotic Agents (Antipsychotics)IBA 11/2017 - 05/2010
6	oxidized low density lipoproteinIBA 05/2022 - 02/2013
6	Messenger RNA (mRNA)IBA 01/2022 - 08/2002
6	Therapeutic UsesIBA 10/2021 - 10/2003
6	Nicorandil (SG 75)IBA 02/2021 - 04/2003
6	MonocrotalineIBA 01/2021 - 02/2009
6	MetalsIBA 02/2018 - 02/2003
6	Angiotensin IIIBA 06/2017 - 04/2006
5	voglibose (Basen)IBA 01/2022 - 07/2014
5	AntibodiesIBA 01/2022 - 01/2003
5	AnticoagulantsIBA 01/2022 - 08/2011
5	DiureticsIBA 01/2022 - 01/2012
5	CreatinineIBA 02/2021 - 01/2016
5	CatecholaminesIBA 01/2021 - 10/2006
5	Interleukin-6 (Interleukin 6)IBA 01/2021 - 07/2012
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2020 - 08/2002
5	3- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidineIBA 01/2020 - 02/2018
5	SmokeIBA 11/2019 - 10/2011
5	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 03/2019 - 01/2010
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019 - 04/2006
5	LigandsIBA 12/2018 - 05/2010
5	Cystatin CIBA 09/2018 - 07/2013
5	Gefitinib (Iressa)FDA Link 11/2017 - 02/2014

Therapy/Procedure

99	Therapeutics 04/2022 - 04/2002
34	Percutaneous Coronary Intervention 05/2022 - 04/2003
12	Stents 02/2022 - 01/2005
12	Drug Therapy (Chemotherapy) 01/2022 - 11/2004
12	Hepatectomy 10/2019 - 10/2003
10	Ligation 04/2022 - 01/2003
10	Catheter Ablation 01/2022 - 10/2017
9	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 12/2017 - 11/2010
7	Catheters 04/2022 - 07/2011
7	Hip Replacement Arthroplasty (Total Hip Replacement) 02/2013 - 09/2003
6	Lasers (Laser) 08/2014 - 12/2008
6	Osteotomy 08/2006 - 07/2004